The study enrolls its 1st participants in trial using mRNA technology developed for the COVID-19 vaccine

The prestigious grant totaling $6.3M was awarded to Dr. Yazdanbakhsh for her exceptional research in sickle cell disease and transfusion therapy

NYBC investigators discovered a set of novel small-molecule pancoronavirus fusion inhibitors.

The American Society of Hematology (ASH), the world’s largest professional society concerned with the causes and treatment of blood disorders...

The grant will be used to complete a five-year research project...

Congratulations to Connie Westhoff, PhD, NYBCe Executive Scientific Director, Immunohematology...

Recent results of the AMP trials showed the feasibility of blocking HIV with bimonthly infusions of broadly neutralizing monoclonal antibodies.

According to existing research, the vaccines create enough antibodies to fight the disease

The new building will anchor and grow NYC’s life science ecosystem

We are very pleased to acknowledge the revised FDA guidelines addressing the urgent need for blood during the COVID-19 pandemic.

Fox 5 Good Day NY's recent segment highlighted the lifesaving power of convalescent plasma donation for critical COVID-19 patients.

Study shows the potential of plasma infusions to help save the lives of critically ill COVID-19 patients.

The grant will fund research into the impact of transfusions in patients with sickle cell disease and how to improve transfusion management.